Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells.
Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that can be used for vaccination purposes, to induce a specific T-cell response in vivo against melanoma-associated antigens. We have shown that the sequential use of early-acting hematopoietic growth factors, stem cell factor, I...
主要な著者: | Mackensen, A, Herbst, B, Chen, J, Köhler, G, Noppen, C, Herr, W, Spagnoli, G, Cerundolo, V, Lindemann, A |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2000
|
類似資料
-
Induction of antigen-specific immune responses in melanoma patients after vaccination with peptide-pulsed dendritic cells.
著者:: Mackensen, A, 等
出版事項: (1999) -
Dendritic Cell Lineage Potential in Human Early Hematopoietic Progenitors
著者:: Julie Helft, 等
出版事項: (2017-07-01) -
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
著者:: Takesako Kazutoh, 等
出版事項: (2005-01-01) -
Transient loading of CD34+ hematopoietic progenitor cells with polystyrene nanoparticles
著者:: Deville S, 等
出版事項: (2017-01-01) -
Generation and function of progenitor T cells from StemRegenin-1–expanded CD34+ human hematopoietic progenitor cells
著者:: Jastaranpreet Singh, 等
出版事項: (2019-10-01)